Taris Biomedical LLC

8 patents currently held · Updated Nov 15, 2026

47 more in force are now held by other companies

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Liris Biomedical, Inc. (2014)

Ending by 2030

Dec 2030

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

2 fees due Feb 18 to 25, 2027 · next Feb 18

Which patents, and when each one lapses · Pro

Recent changes

1 term has ended since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

Patent	Title	Status	Expires	Confidence
US 12,576,253	Drug Delivery Device with Intravesical Tolerability In force Term ends Dec 17, 2030 · High confidence	In force	Term ends Dec 17, 2030	High confidence
US 9,492,266	Ureteral Stent Drug Delivery Device, Kit, and Method In force Term ends Oct 2, 2031 · High confidence	In force	Term ends Oct 2, 2031	High confidence
US 9,457,176	Implantable Drug Delivery Device with Bladder Retention Feature In force Term ends Oct 6, 2031 · High confidence	In force	Term ends Oct 6, 2031	High confidence
US 9,114,111	Methods for Sustained Treatment of Bladder Pain and Irritative Voiding In force Term ends Jan 10, 2032 · High confidence	In force	Term ends Jan 10, 2032	High confidence
US 9,107,816	Implantable Device for Controlled Dissolution and Diffusion of Low Solubility Drug In force Term ends Feb 6, 2032 · High confidence	In force	Term ends Feb 6, 2032	High confidence
US 12,582,599	Methods for Treatment of Bladder Cancer with Gemcitabine In force Term ends Mar 6, 2035 · Medium confidence	In force	Term ends Mar 6, 2035	Medium confidence
US 10,857,336	Implantable urological device with improved retrieval feature In force Term ends Feb 20, 2036 · From the USPTO record	In force	Term ends Feb 20, 2036	From the USPTO record
US 12,214,148	Multi-lumen drug delivery devices and methods In force Term ends Nov 17, 2038 · From the USPTO record	In force	Term ends Nov 17, 2038	From the USPTO record

Also on record, not counted in the 8: 47 patents in force now held by others · 11 lapsed for an unpaid fee · 1 ended at full term · 1 past the fee grace period. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 10 abandoned · 7 no status recorded

List them